We found that 12 studies not only evaluated prognosis value of LMP1 expression, but also other parameters, such as the association between the expression of EBV-encoded Epstein-Barr virus early RNAs (EBERs) and the prognosis of lymphoma; thus, data on LMP1 expression and survival were not able to be specifically retrieved [35]–[46]; 4 studies were lacking relevant and convincing survival data [47]–[50]; 2 studies were review papers without actual data [51], [52]; one study was lack of data on overall survival [53], and another study was duplicate reported [54]. This evidence concerns the gene PDLIM7 and lymphoma.